Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5668)
All Articles published online
|
Apr 7, 2012 (publication date) through Nov 5, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Ansari D, Chen BC, Dong L, Zhou MT, Andersson R. Pancreatic cancer: Translational research aspects and clinical implications. World J Gastroenterol 2012; 18(13): 1417-1424 [PMID: 22509073 DOI: 10.3748/wjg.v18.i13.1417] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v18/i13/1417.htm |
| Number | Citing Articles |
| 1 |
Lorella Vecchio, Paul Faustin Seke Etet, Maulilio John Kipanyula, Mauro Krampera, Armel Hervé Nwabo Kamdje. Importance of epigenetic changes in cancer etiology, pathogenesis, clinical profiling, and treatment: What can be learned from hematologic malignancies?. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2013; 1836(1): 90 doi: 10.1016/j.bbcan.2013.04.001
|
| 2 |
Randa G. Hanna-Sawires, Jorinde H. Schiphuis, Manfred Wuhrer, Hans F. A. Vasen, Monique E. van Leerdam, Bert A. Bonsing, Wilma E. Mesker, Yuri E. M. van der Burgt, Rob A. E. M. Tollenaar. Clinical Perspective on Proteomic and Glycomic Biomarkers for Diagnosis, Prognosis, and Prediction of Pancreatic Cancer. International Journal of Molecular Sciences 2021; 22(5): 2655 doi: 10.3390/ijms22052655
|
| 3 |
Shota Kuwabara, Takahiro Tsuchikawa, Toru Nakamura, Yutaka Hatanaka, Kanako C. Hatanaka, Katsunori Sasaki, Masato Ono, Kazufumi Umemoto, Tomohiro Suzuki, Osamu Sato, Yuma Hane, Yoshitsugu Nakanishi, Toshimichi Asano, Yuma Ebihara, Yo Kurashima, Takehiro Noji, Soichi Murakami, Keisuke Okamura, Toshiaki Shichinohe, Satoshi Hirano. Prognostic relevance of tertiary lymphoid organs following neoadjuvant chemoradiotherapy in pancreatic ductal adenocarcinoma. Cancer Science 2019; 110(6): 1853 doi: 10.1111/cas.14023
|
| 4 |
Mehmet ZENGİN. A different perspective to the tumor microenvironment in periampullary cancers: a neglected ring in tumorogenesis.. Journal of Health Sciences and Medicine 2019; 2(1): 1 doi: 10.32322/jhsm.453541
|
| 5 |
Takahiro Tsuchikawa, Satoshi Hirano, Toru Nakamura, Keisuke Okamura, Eiji Tamoto, Toshiaki Shichinohe. Concomitant major vessel resection in pancreatic adenocarcinoma. Postgraduate Medicine 2015; 127(3): 273 doi: 10.1080/00325481.2015.1032180
|
| 6 |
Takahiro Tsuchikawa, Satoshi Hirano, Eiichi Tanaka, Joe Matsumoto, Kentaro Kato, Toru Nakamura, Yuma Ebihara, Toshiaki Shichinohe. Novel aspects of preoperative chemoradiation therapy improving anti‐tumor immunity in pancreatic cancer. Cancer Science 2013; 104(5): 531 doi: 10.1111/cas.12119
|
| 7 |
David Padilla-Valverde, Raquel Bodoque-Villar, Esther García-Santos, Susana Sanchez, Carmen Manzanares-Campillo, Marta Rodriguez, Lucia González, Alfonso Ambrós, Juana M. Cano, Maria Padilla-Marcote, Javier Redondo-Calvo, Jesus Martin, Leticia Serrano-Oviedo. Safety and Effectiveness of Perioperative Hyperthermic Intraperitoneal Chemotherapy with Gemcitabine in Patients with Resected Pancreatic Ductal Adenocarcinoma: Clinical Trial EudraCT 2016-004298-41. Cancers 2024; 16(9): 1718 doi: 10.3390/cancers16091718
|
| 8 |
Syed F Zafar, Ganji Purnachandra Nagaraju, Bassel El-Rayes. Developing histone deacetylase inhibitors in the therapeutic armamentarium of pancreatic adenocarcinoma. Expert Opinion on Therapeutic Targets 2012; 16(7): 707 doi: 10.1517/14728222.2012.691473
|
| 9 |
Gabriela Kramer-Marek, Jesse Gore, Murray Korc. Molecular imaging in pancreatic cancer – A roadmap for therapeutic decisions. Cancer Letters 2013; 341(2): 132 doi: 10.1016/j.canlet.2013.08.008
|
| 10 |
Minnie Au, Theophilus Emeto, Jacinta Power, Venkat Vangaveti, Hock Lai. Emerging Therapeutic Potential of Nanoparticles in Pancreatic Cancer: A Systematic Review of Clinical Trials. Biomedicines 2016; 4(3): 20 doi: 10.3390/biomedicines4030020
|
| 11 |
Gerda C. M. Vreeker, Randa G. Hanna‐Sawires, Yassene Mohammed, Marco R. Bladergroen, Simone Nicolardi, Viktoria Dotz, Jan Nouta, Bert A. Bonsing, Wilma E. Mesker, Yuri E. M. van der Burgt, Manfred Wuhrer, Rob A. E. M. Tollenaar. Serum N‐Glycome analysis reveals pancreatic cancer disease signatures. Cancer Medicine 2020; 9(22): 8519 doi: 10.1002/cam4.3439
|
| 12 |
Armel Hervé Nwabo Kamdje, Hervet Paulain Dongmo Fogang, Patrice N. Mimche. Role of epigenetic in cancer biology, in hematologic malignancies and in anticancer therapy. Frontiers in Molecular Medicine 2024; 4 doi: 10.3389/fmmed.2024.1426454
|
| 13 |
Jorge Alberto Guadarrama-Orozco, Erika Ruiz-Garcia, Juan Carlos Casarez-Price, Samuel Rivera-Rivera, Horacio Astudillo-de la Vega. Stem Cells in Cancer: Should We Believe or Not?. 2014; : 167 doi: 10.1007/978-94-017-8754-3_8
|
| 14 |
Tao Sun, Xiangyu Kong, Yiqi Du, Zhaoshen Li. Aberrant MicroRNAs in Pancreatic Cancer: Researches and Clinical Implications. Gastroenterology Research and Practice 2014; 2014: 1 doi: 10.1155/2014/386561
|
| 15 |
Yiqi Du, Minghao Liu, Jun Gao, Zhaoshen Li. Aberrant MicroRNAs Expression Patterns in Pancreatic Cancer and Their Clinical Translation. Cancer Biotherapy and Radiopharmaceuticals 2013; 28(5): 361 doi: 10.1089/cbr.2012.1389
|
| 16 |
Daisuke Sato, Takahiro Tsuchikawa, Tomoko Mitsuhashi, Yutaka Hatanaka, Katsuji Marukawa, Asami Morooka, Toru Nakamura, Toshiaki Shichinohe, Yoshihiro Matsuno, Satoshi Hirano, Edna Cukierman. Stromal Palladin Expression Is an Independent Prognostic Factor in Pancreatic Ductal Adenocarcinoma. PLOS ONE 2016; 11(3): e0152523 doi: 10.1371/journal.pone.0152523
|